Wallop of Symptoms and Co-morbidities on COVID-19 Outcome
Mohamed Abdellatif1
Haroun BG1
Basem Elnagdy1
Taghreed Ashraf1
Bahaa ElNaggar1
Passant S. Eldin1
Ismail TA1
Beshoy Mosaad1
Tasbeeha Ismail1
Rasmy Boules1
Shawky Methuselah1
Paula Rafaat1
Authors Info & Affiliations
Abstract
Background:
Fever, cough, fatigue, and myalgia are usually the original clinical picture of the COVID-19 pandemic, which appears non-specific and not exclusive.
Objectives:
To illustrate the clinical picture pattern and assess the prevalence of underlying co-morbidities and their correlation with the severity of COVID-19 infected patients.
Methods:
A cross-sectional online survey included 580 participants who were either suspected or confirmed with COVID-19 infection.
Results:
The severity of the disease significantly correlates with both age (p=.01) and the time lag of the diagnosis of COVID-19 (p=.03). Hypertension (p=.015) and diabetes mellitus (p<.01) were significantly associated with the duration of symptoms. A wide range of ages (21-60 years) seemed to be the only risk factor for the severity. When symptoms were tested, dyspnea appeared to be the most prevalent symptom, predicting a more severe disease (OR= .066, 95% CI: .022- .200), followed by diarrhea (OR= .285, 95% CI: .122-.663), then fever (OR= .339, 95% CI: .139-.824). During the examination of co-morbidities influences on the severity, the only major co-morbidity that predicted a more severe disease was IHD (OR= .218, 95% CI: .073- .648), p= .006.
Conclusion:
Special consideration is required for patients with COVID-19 with an associated longer gap between symptoms and diagnosis and associated co-morbidities including hypertension, diabetes, and established chronic kidney disease (CKD), for which this study proved its profound influence on the severity of the illness and duration of symptoms.
